Brands: Lopid · Gemfibrozil
Average across 10 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Aphena Pharma Solutions - Tennessee, LLC | unknown | 7 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 5 | SUPPLYING |
| A-S Medication Solutions | unknown | 5 | SUPPLYING |
| Exelan Pharmaceuticals, Inc. | unknown | 3 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 3 | SUPPLYING |
| Chartwell RX, LLC. | unknown | 2 | SUPPLYING |
| NorthStar Rx LLC | unknown | 2 | SUPPLYING |
| Parke-Davis Div of Pfizer Inc | unknown | 2 | SUPPLYING |
| Rising Pharma Holdings, Inc. | unknown | 2 | SUPPLYING |
| NCS HealthCare of KY, LLC dba Vangard Labs | unknown | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Gemfibrozil Tablet — reported in shortage by Pfizer Inc.. Therapeutic category: Endocrinology/Metabolism.
Gemfibrozil Tablet — reported in shortage by Pfizer Inc.. Therapeutic category: Endocrinology/Metabolism.
Pill